The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company ...
India's drug regulator has issued a critical warning regarding the illegal sale of single-drug artemisinin formulations, ...
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...
The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...
The Central Drugs Standard Control Organisation (CDSCO) is considering introducing new rules to stop the industry practice of ...
TipRanks on MSN
BioCryst gains FDA approval for pediatric HAE drug
BioCryst ( ($BCRX) ) has provided an announcement. On December 12, 2025, BioCryst Pharmaceuticals announced the FDA approval of its new drug ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four ...
The US Food and Drug Administration (FDA) agency is proposing to add bemotrizinol as a permitted active ingredient for use in ...
Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...
The U.S. has been missing out on some of the world's best sunscreens, but we're finally getting bemotrizinol, and I'm excited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback